LONDON/COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President ...

Welcome to the Q1 2025 Novo Nordisk A/S Earnings Conference Call ... Indiana and Casa, North Carolina. The existing U.S. tariffs does not materially change our financial outlook for 2025.

Pharmaceutical company Novo Nordisk (NVO) came out swinging Wednesday ... It's biologic manufacturing taking place in North Carolina and supplied to Americans. So we are proud about that, and ...

Coming up, we've got our conversation with the CEO Novo Nordisk as the company trims ... It's biological.manufacturing taking place in North Carolina and uh supplied to to to Americans so we ...

Illinois-based Wylie Capital Will Build $55 Million Commerce Hub in Clayton CLAYTON – On Monday, Johnston County Commissioners unanimously approved an economic development agreement with ...

LONDON/COPENHAGEN, May 7 (Reuters) - Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President Donald Trump's executive order to reduce the time it takes to ...

Weight-loss drug maker Novo Nordisk reported an earnings beat, but sales fell short of expectations. Management gave an encouraging outlook for the rest of 2025. Novo Nordisk trades for less than ...

Novo Nordisk NOVO.B6.64%increase; green up pointing triangle lowered its full-year guidance as copycat versions of its blockbuster weight-loss and diabetes drugs in the U.S. hold back sales of its ...